YOUR GO-TO INTELLIGENCE RESOURCE FOR THE SCHOLARLY PUBLISHING INDUSTRY

Wolters Kluwer Health, following its acquisition of Invistics, is celebrating the exceptional recognition received by its drug diversion monitoring software in the recently published KLAS Drug Diversion Monitoring 2023 report. This AI-based solution has been acknowledged for its effectiveness in combating drug diversion within healthcare facilities, emphasizing its critical role in enhancing patient safety and maintaining the integrity of the healthcare system.

Drug diversion, the illicit redirection of prescription drugs for personal use or sale, poses a significant threat to patient well-being, healthcare providers, and the healthcare system as a whole. According to estimates from the International Health Facility Diversion Association, approximately 37,000 diversion incidents occur in U.S. healthcare facilities annually, with many cases going unreported. Swiftly identifying and preventing drug diversion is crucial for patient safety and ensuring that clinical staff facing substance use disorder receive the necessary support and resources promptly.

The KLAS report shines a spotlight on the drug diversion challenge and the pivotal role played by Wolters Kluwer's recently acquired drug diversion solution. Key findings from the report include: Satisfied Customers: Respondents expressed satisfaction with the platform's AI capabilities, particularly praising its risk-scoring reports and its ability to identify potential diversions. The AI continuously learns from user facilities, enabling customizable alerts tailored to each hospital's unique requirements; Positive Long-Term Outlook: Respondents conveyed that the solution is integral to their long-term plans, expressing optimism about the future. They lauded the vendor for its responsiveness to their feedback; Proactive and Quality Support: Customers commended the vendor's proactive support, highlighting their accessibility to executive leadership and affirming the vendor's commitment to fulfilling promises. The quality of phone and web support further attested to the organization's dedication to providing top-tier customer assistance; and Investigative Guidance: Wolters Kluwer's Invistics received a 'Good' rating in the 'Analytics accurately highlight investigational needs' category. This underscores the solution's ability to pinpoint areas requiring further investigation.

Wolters Kluwer Health's drug diversion solution stands as a testament to the evolving landscape of AI-driven healthcare technologies, offering earlier detection and interventions to enhance patient safety and mitigate risks for clinical teams and hospitals.